Pre-Market Earnings Report for February 10, 2026 : KO, SPGI, CVS, DUK, MAR, SPOT, ECL, RACE, DDOG, XYL, FISV, BP

Ahead of the Feb. 10, 2026 pre-market open, a batch of large-cap companies are due to report December-quarter results with mixed consensus EPS trajectories: Coca-Cola (KO) $0.56 est. (+1.82% YoY), S&P Global (SPGI) $4.32 (+14.59%), CVS Health (CVS) $0.99 (-16.81%), Duke Energy (DUK) $1.51 (-9.04%), Marriott (MAR) $2.64 (+7.76%), Spotify (SPOT) $2.95 (+56.91%), Ecolab (ECL) $2.06 (+13.81%), Ferrari (RACE) $2.44 (+7.02%), Datadog (DDOG) $0.14 (+7.69%), Xylem (XYL) $1.41 (+19.49%), Fiserv (FISV) $1.90 (-24.30%) and BP (BP) $0.57 (+29.55%). Zacks P/E context is noted for several names (e.g., KO 26.43 vs industry 54.90; SPGI 24.61 vs 22.30; FISV 7.02 vs 13.30), underscoring varied valuation and growth expectations; traders should expect idiosyncratic stock moves rather than a unified market direction.

Analysis

Market structure: Earnings show a bifurcated market — data/fees (SPGI +14.6% EPS est), streaming/scale (SPOT +56.9%) and energy (BP +29.6%) are positioned as winners while payments (FISV -24.3% est), healthcare retail (CVS -16.8%) and utilities (DUK -9.0%) face near-term pressure. Expect rotation from rate-sensitive defensives into cyclicals and commodities if BP/SPGI prints sustain guidance; KO (EPS +1.8%, P/E 26.4) remains a defensive anchor with lower volatility. Cross-asset: a strong BP print will lift crude, push inflation prints higher and steepen front-end yields, boosting commodity currencies (CAD/NOK) and FX volatility; option IV will spike most in FISV, DDOG and SPOT around earnings windows.

Risk assessment: Tail risks include regulatory scrutiny on financial/data fees (SPGI) and payments regulation or client loss at FISV, as well as an oil-price shock from geopolitical events that could flip sentiment in 48–72 hours. Immediate (0–5 days) risk is earnings-guidance surprise; short-term (1–3 months) is macro-driven repositioning; long-term (3–12 months) depends on secular trends — streaming monetization for SPOT and healthcare reimbursement pressures for CVS. Hidden dependencies: consumer discretionary strength drives MAR/RACE while interest-rate moves disproportionately hit DUK and long-duration software names (DDOG).

Trade implications: Be tactical: favor SPGI and BP exposure on confirmed guidance beats and cash-flow commentary (target +15–25% in 3–6 months), and use option structures to contain drawdowns into earnings. Short/hedge FISV on a miss with 1–3 month put spreads sized to 0.5–1.0% portfolio risk; buy call spreads on SPOT (1–2 month) instead of naked calls to limit IV risk. Rotate 1% portfolio from utilities (DUK) into industrials/water-tech (XYL) if XYL posts >5% beat and guidance upgrades, targeting 8–12% relative upside in 3 months.

Contrarian angles: The market may be overselling FISV (P/E 7.0) if management addresses the 3Q miss with buybacks or contracts — a tactical deep-value rebound is possible within 6–12 weeks post-guidance revision. Conversely, SPOT's large consensus beat expectation amplifies downside from any margin or ad-mix disappointment; consider selling short-dated calls into strength. Historical parallel: data/fee businesses (S&P‑like models) re-rate on sustainable fee expansion, not one-quarter beats, so price moves post-earnings can be durable only if guidance changes the multi-quarter trajectory.

Key Decisions for Investors

• Establish a 1–1.5% long position in SPGI within 24 hours after earnings if EPS ≥ $4.32 and management raises FY26 guidance; set a 10% stop and a 20% target over 3–6 months.
• Initiate a 0.5–1.0% downside hedge on FISV via a 1–3 month put spread (buy 1 ATM/10% OTM put, sell 1 deeper 25% OTM put) sized to cap risk at ~0.5% portfolio — increase to a 1% short if earnings miss >15% and guidance is cut.
• Buy a 1-month SPOT call debit spread (ATM to +15% strike) allocating 0.5–0.8% portfolio risk ahead of release to capture expected upside while limiting IV exposure; close within 10 trading days or on a 30% profit.
• Execute a pair trade: long XYL (1% position) vs short DUK (1% position) after earnings if XYL beats by >5% and DUK misses by >5%; target 10% relative outperformance within 3 months and stop the pair if divergence narrows to 3%.
• Reduce aggregate exposure to long-duration, rate-sensitive equities by 50 bps and buy 3–6 week protection on interest-rate-sensitive sectors (e.g., 1× put spread on XLU) if front-end yields steepen >20 bps on BP/SPGI prints.